SeaStar Medical Holding (ICU) Assets Average (2021 - 2026)
SeaStar Medical Holding's (ICU) quarterly Assets Average came in at $12.7 million in Q1 2026, up 34.5% YoY from $9.4 million in Q1 2025, and down 14.29% on a QoQ basis from $14.8 million in Q4 2025.
SeaStar Medical Holding (ICU) Assets Average (2021 - 2026) Analysis & Trends
SeaStar Medical Holding (ICU) has 6 years of Assets Average data on file, last reported at $12.7 million in Q1 2026.
- Quarterly Assets Average rose 34.5% year-over-year to $12.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $12.7 million (up 34.5% YoY) and the FY2025 annual result came in at $9.4 million, up 129.61% from the prior year.
- Assets Average eased to $12.7 million in Q1 2026, from $14.8 million in the prior quarter.
- In the past five years, Assets Average ranged from a high of $106.6 million in Q3 2022 to a low of $2.6 million in Q3 2023.
- A 5-year average of $24.3 million and a median of $9.4 million in 2025 frame the typical range for Assets Average.
- Annual changes were most pronounced in 2023 — Assets Average slumped 97.61% — and 2025, when it surged 219.38%.
- Tracing ICU's Assets Average over 5 years: stood at $55.2 million in 2022, then plunged by 94.55% to $3.0 million in 2023, then soared by 54.23% to $4.6 million in 2024, then surged by 219.38% to $14.8 million in 2025, then retreated by 14.29% to $12.7 million in 2026.
- The last three Assets Average figures came in at $12.7 million (Q1 2026), $14.8 million (Q4 2025), and $12.0 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.25 Bn | 131.40 Bn | 2.84 Bn | 26.95 Bn |
| 2 | Regeneron Pharmaceuticals | 86.04 Bn | 78.05 Bn | 3.93 Bn | 41.30 Bn |
| 3 | Argenx Se | 65.43 Bn | 60.25 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.26 Bn | 53.13 Bn | 52.00 Mn | 11.22 Bn |
| 5 | BeOne Medicines | 42.10 Bn | 37.00 Bn | 1.53 Bn | 8.86 Bn |
| 6 | Alnylam Pharmaceuticals | 31.61 Bn | 28.31 Bn | 992.69 Mn | 5.34 Bn |
| 7 | BioNTech SE | 28.03 Bn | 9.63 Bn | 668.28 Mn | 25.27 Bn |
| 8 | Insmed | 27.49 Bn | 26.33 Bn | 358.27 Mn | 2.09 Bn |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - | 19.82 Bn |
| 10 | SeaStar Medical Holding | 14.11 Mn | 7.11 Mn | 561,000.00 | 9.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 9.97 Mn |
| Mar 31, 2026 | 12.71 Mn |
| Dec 31, 2025 | 14.83 Mn |
| Sep 30, 2025 | 11.95 Mn |
| Jun 30, 2025 | 11.30 Mn |
| Mar 31, 2025 | 9.45 Mn |
| Dec 31, 2024 | 4.64 Mn |
| Sep 30, 2024 | 4.03 Mn |
| Jun 30, 2024 | 5.60 Mn |
| Mar 31, 2024 | 5.63 Mn |
| Dec 31, 2023 | 3.01 Mn |
| Sep 30, 2023 | 2.55 Mn |
| Jun 30, 2023 | 3.12 Mn |
| Mar 31, 2023 | 3.34 Mn |
| Dec 31, 2022 | 55.19 Mn |
| Sep 30, 2022 | 106.65 Mn |
| Jun 30, 2022 | 105.96 Mn |
| Mar 31, 2022 | 53.28 Mn |
| Dec 31, 2021 | 53.40 Mn |
| Sep 30, 2021 | 106.36 Mn |